Niemann-Pick Type C-2 Disease: Identification by Analysis of Plasma Cholestane-3β,5α,6β-Triol and Further Insight into the Clinical Phenotype.
暂无分享,去创建一个
O. Sommerburg | I. Borggraefe | B. Bembi | M. Fobker | M. Griese | T. Marquardt | A. Burlina | G. Polo | M. Mall | E. Mengel | A. Dardis | J. Reunert | A. Muntau | A. Lotz-Havla | G. Ciana | A. Burlina | F. Kannenberg | P. Schnabel
[1] E. Bertini,et al. A new simple and rapid LC-ESI-MS/MS method for quantification of plasma oxysterols as dimethylaminobutyrate esters. Its successful use for the diagnosis of Niemann-Pick type C disease. , 2014, Clinica chimica acta; international journal of clinical chemistry.
[2] Xuefan Gu,et al. Determination of 7-ketocholesterol in plasma by LC-MS for rapid diagnosis of acid SMase-deficient Niemann-Pick disease , 2014, Journal of Lipid Research.
[3] F. Sedel,et al. Niemann-Pick disease type C symptomatology: an expert-based clinical description , 2013, Orphanet Journal of Rare Diseases.
[4] E. Elahi,et al. Identification of mutation in NPC2 by exome sequencing results in diagnosis of Niemann-Pick disease type C. , 2013, Molecular genetics and metabolism.
[5] F. Sedel,et al. Recommendations for the diagnosis and management of Niemann-Pick disease type C: an update. , 2012, Molecular genetics and metabolism.
[6] Anneliese O. Speak,et al. A sensitive and specific LC-MS/MS method for rapid diagnosis of Niemann-Pick C1 disease from human plasma[S] , 2011, Journal of Lipid Research.
[7] C. Vite,et al. Cholesterol Oxidation Products Are Sensitive and Specific Blood-Based Biomarkers for Niemann-Pick C1 Disease , 2010, Science Translational Medicine.
[8] A. Shabani,et al. Successful allogeneic bone marrow transplant for Niemann–Pick disease type C2 is likely to be associated with a severe ‘graft versus substrate’ effect , 2010, Journal of Inherited Metabolic Disease.
[9] E. Ikonen,et al. Respiratory disease in Niemann‐Pick type C2 is caused by pulmonary alveolar proteinosis , 2010, Clinical genetics.
[10] M. Baumgartner,et al. Recommendations on the diagnosis and management of Niemann-Pick disease type C. , 2009, Molecular genetics and metabolism.
[11] J. Storch,et al. Niemann-Pick C2 (NPC2) and intracellular cholesterol trafficking. , 2009, Biochimica et biophysica acta.
[12] B. Bembi,et al. Oxidative stress in NPC1 deficient cells: protective effect of allopregnanolone , 2008, Journal of cellular and molecular medicine.
[13] G. Millat,et al. Niemann–Pick C disease: functional characterization of three NPC2 mutations and clinical and molecular update on patients with NPC2 , 2007, Clinical genetics.
[14] S. Pfeffer,et al. Clues to Neuro-Degeneration in Niemann-Pick Type C Disease from Global Gene Expression Profiling , 2006, PloS one.
[15] F. Krummenauer,et al. Critical assessment of chitotriosidase analysis in the rational laboratory diagnosis of children with Gaucher disease and Niemann–Pick disease type A/B and C , 2006, Journal of Inherited Metabolic Disease.
[16] G. Millat,et al. Niemann-Pick C disease: use of denaturing high performance liquid chromatography for the detection of NPC1 and NPC2 genetic variations and impact on management of patients and families. , 2005, Molecular genetics and metabolism.
[17] H. Klein,et al. Frontal lobe atrophy due to a mutation in the cholesterol binding protein HE1/NPC2 , 2002, Annals of neurology.
[18] K. Higaki,et al. Niemann-Pick disease type C: spectrum of HE1 mutations and genotype/phenotype correlations in the NPC2 group. , 2001, American journal of human genetics.
[19] Y. Ioannou,et al. Niemann-Pick C1 is a late endosome-resident protein that transiently associates with lysosomes and the trans-Golgi network. , 1999, Molecular genetics and metabolism.
[20] T. Baba,et al. A porcine homolog of the major secretory protein of human epididymis, HE1, specifically binds cholesterol. , 1999, Biochimica et biophysica acta.
[21] M. Vanier,et al. Early-lethal pulmonary form of Niemann-Pick type C disease belonging to a second, rare genetic complementation group , 1998, European Journal of Pediatrics.
[22] K. G. Coleman,et al. Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis. , 1997, Science.
[23] W. J. Johnson,et al. Cholesterol quantitation by GLC: artifactual formation of short-chain steryl esters. , 1995, Journal of lipid research.
[24] C. Hollak,et al. Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease. , 1994, The Journal of clinical investigation.
[25] R. Rousson,et al. Type C Niemann-Pick disease: spectrum of phenotypic variation in disruption of intracellular LDL-derived cholesterol processing. , 1991, Biochimica et biophysica acta.
[26] R. Brady,et al. Type-C Niemann-Pick disease: low density lipoprotein uptake is associated with premature cholesterol accumulation in the Golgi complex and excessive cholesterol storage in lysosomes. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[27] 张静,et al. Banana Ovate family protein MaOFP1 and MADS-box protein MuMADS1 antagonistically regulated banana fruit ripening , 2015 .
[28] M. Minczuk,et al. Two siblings with myopathy, mild mental retardation and combined OXPHOS deficiencies caused by a mutation in the gene encoding asparaginyl tRNA synthetase, NARS2 , 2014 .
[29] J. E. Wraith,et al. Developmental outcome post allogenic bone marrow transplant for Niemann Pick Type C2. , 2013, Molecular genetics and metabolism.